Strata PATH™ (Precision Indications for Approved Therapies)
Status:
Not yet recruiting
Trial end date:
2029-10-21
Target enrollment:
Participant gender:
Summary
StrataPATH is a non-randomized, open-label trial designed to explore efficacy and safety of
multiple FDA-approved and commercially available cancer therapies in new, biomarker-guided
patient populations.